The deal would enhance Gilead’s portfolio in Oncology and would enable the agency to conduct new First-in-Class oncology applications. Gilead Sciences Inc., a U.S. primarily…
April 14, 2021
The deal would enhance Gilead’s portfolio in Oncology and would enable the agency to conduct new First-in-Class oncology applications. Gilead Sciences Inc., a U.S. primarily…